Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

AbbVie Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

07 May 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - AbbVie Inc (ABBV-N)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

19 May 2016 Thomson Reuters Stock Report 12 $25.00

Company Snapshot - Abbvie Inc

Two Directors at Abbvie Inc sold after exercising options/sold 53,438 shares at between 63.520USD and 63.590USD. The signific...

13 May 2016 Directors Deals Ltd. 1 $12.00

Trading Report for (ABBV). A detailed report, including free correlated market analysis, and updates.

Detailed Trading Report for ABBV. Entry levels, target prices, and risk controls are integral. In addition, free market anal...

13 May 2016 Stock Traders Daily 6 $20.00

ABBV: Due Diligence Review: Forensic Earnings and Valuation

Reports provide superior value and incorporate critical data from the Financial Footnotes and MD&A that other firms miss. The...

13 May 2016 New Constructs, LLC 10 $25.00

Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ABBVIE INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.

13 May 2016 Jefferson Research 11 $20.00

AbbVie Inc. (ABBV) - Financial and Strategic SWOT Analysis Review

AbbVie Inc. (ABBV) - Financial and Strategic SWOT Analysis Review Summary AbbVie Inc. (AbbVie) is a research-based biopharmac...

11 May 2016 GlobalData 164 $300.00

Thomson Reuters Stock Report - AbbVie Inc (ABBV-N)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

11 May 2016 Thomson Reuters Stock Report 12 $25.00

AbbVie Inc

09 May 2016 S&P Capital IQ – STARS Reports 11 $127.00

Abbvie (NYSE- ABBV)

AbbVie is a global, research-based biopharmaceutical company formed in 2013 following its separation from Abbott Laboratorie...

09 May 2016 Acquisdata 10 $15.00